Study Comparing Tenofovir Disoproxil Fumarate (TDF), Emtricitabine (FTC)/TDF, and Entecavir (ETV) in the Treatment of Chronic HBV in Subjects With Decompensated Liver Disease.

NCT00298363 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Tenofovir disoproxil fumarate (tenofovir DF; TDF)
DRUG: Emtricitabine/tenofovir disoproxil fumarate (FTC/TDF)
DRUG: Entecavir (ETV)
DRUG: TDF placebo
DRUG: FTC/TDF placebo
DRUG: ETV placebo

Sponsor

Gilead Sciences